| GlucoCEST MRI in Oncology (NCT03212157) | University College, London | 2017-01-06 |
| PET Guided Bone Marrow Biopsy vs Trephine Bone Marrow Biopsy (NCT05251168) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2017-01-01 |
| A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (NCT02760485) | Incyte Corporation | 2016-12-29 |
| CAR-T Therapy in Relapsed or Refractory Haematopoietic and Lymphoid Malignancies (NCT03121625) | Hebei Senlang Biotechnology Inc., Ltd. | 2016-12-26 |
| Ixazomib Rollover Study (NCT02924272) | Takeda | 2016-12-16 |
| Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS (NCT02730299) | Gamida Cell ltd | 2016-12-16 |
| Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer (NCT02856048) | Assistance Publique - Hôpitaux de Paris | 2016-11-23 |
| Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials (NCT02948413) | National Institutes of Health Clinical Center (CC) | 2016-11-10 |
| A Study Evaluating Safety and Efficacy of Obinutuzumab, Polatuzumab Vedotin (Pola), and Atezolizumab (Atezo) in Participants With Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab, Atezo, and Pola in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02729896) | Hoffmann-La Roche | 2016-11-09 |
| Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors (NCT03061305) | Strata Oncology | 2016-11-01 |
| Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma (NCT02974647) | Memorial Sloan Kettering Cancer Center | 2016-11-01 |
| A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma (NCT03070964) | PharmaMar | 2016-10-25 |
| Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer (NCT02800889) | CTI BioPharma | 2016-10-24 |
| A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) (NCT02857426) | Bristol-Myers Squibb | 2016-10-21 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients (NCT02963389) | Dong-A ST Co., Ltd. | 2016-10-04 |
| Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment (NCT02932280) | Memorial Sloan Kettering Cancer Center | 2016-10-01 |
| Helicobacter Pylori Antibiotic Susceptibility Testing of Korea (NCT02961296) | Asan Medical Center | 2016-10-01 |
| CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT (NCT02942173) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2016-10-01 |
| EBUS-TBNA vs Flex 19G EBUS-TBNA (NCT02916459) | Heidelberg University | 2016-10-01 |
| Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma (NCT02909777) | Dana-Farber Cancer Institute | 2016-10-01 |
| A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies (NCT02958410) | Southwest Hospital, China | 2016-10-01 |
| A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies (NCT02954445) | Southwest Hospital, China | 2016-10-01 |
| Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas (NCT02875002) | Yale University | 2016-10-01 |
| Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation (NCT03010579) | Peking University | 2016-10-01 |
| Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) (NCT02704832) | Institut Bergonié | 2016-09-30 |
| G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor (NCT02933333) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2016-09-27 |
| PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage (NCT02918747) | Hunan Cancer Hospital | 2016-09-01 |
| Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL (NCT02690545) | UNC Lineberger Comprehensive Cancer Center | 2016-08-26 |
| Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma (NCT03167476) | University of Electronic Science and Technology of China | 2016-08-01 |
| Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma (NCT03422874) | Dartmouth-Hitchcock Medical Center | 2016-08-01 |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) (NCT02624388) | University of Virginia | 2016-08-01 |
| Enhancing Diagnosis in Chronic B-cell Lymphoproliferative Disorders Using Next-Generation Sequencing (NCT03344809) | Royal Marsden NHS Foundation Trust | 2016-08-01 |
| Study of ACTR087 in Subjects With Relapsed or Refractory B-cell Lymphoma (NCT02776813) | Cogent Biosciences, Inc. | 2016-08-01 |
| A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6) (NCT02576665) | Tocagen Inc. | 2016-07-01 |
| Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant (NCT02477878) | Bellicum Pharmaceuticals | 2016-07-01 |
| Durvalumab in Pediatric and Adolescent Patients (NCT02793466) | Leo Mascarenhas | 2016-07-01 |
| Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab (NCT03200977) | Bristol-Myers Squibb | 2016-07-01 |
| Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies (NCT02795182) | BeiGene | 2016-06-29 |
| Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype (NCT02589145) | M.D. Anderson Cancer Center | 2016-06-22 |
| Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence (NCT02681302) | Hackensack Meridian Health | 2016-06-07 |
| Administration of T Lymphocytes for Prevention of Relapse of Lymphomas (NCT02663297) | UNC Lineberger Comprehensive Cancer Center | 2016-06-07 |
| Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma (NCT02272686) | M.D. Anderson Cancer Center | 2016-06-03 |
| Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed Lymphoma (NCT02701673) | M.D. Anderson Cancer Center | 2016-06-01 |
| Phase 2 Study With PQR309 in Relapsed or Refractory Lymphoma Patients (NCT03127020) | PIQUR Therapeutics AG | 2016-06-01 |
| The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy (NCT02905916) | Peking University | 2016-06-01 |
| Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas (NCT02783625) | Memorial Sloan Kettering Cancer Center | 2016-05-23 |
| A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia (NCT02733042) | Celgene | 2016-05-11 |
| A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma (NCT02756247) | Memorial Sloan Kettering Cancer Center | 2016-05-09 |
| EBUS-TBNA vs Flex 19G EBUS-TBNA (NCT02592837) | Royal Brompton & Harefield NHS Foundation Trust | 2016-05-01 |
| Early Life Exposures in Agriculture (NCT02743481) | National Cancer Institute (NCI) | 2016-04-14 |
| PERCIST Criteria for Response Evaluation With Solid Tumors (NCT02765620) | Tianjin Medical University Cancer Institute and Hospital | 2016-04-01 |
| PET Imaging of Subjects Using 124I-PU-AD (NCT03371420) | Samus Therapeutics, Inc. | 2016-04-01 |
| Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) (NCT02766842) | Johns Hopkins University | 2016-04-01 |
| TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma (NCT02652468) | University of Wisconsin, Madison | 2016-03-10 |
| A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies (NCT02710149) | Southwest Hospital, China | 2016-03-01 |
| Medical Treatment Decision Making Using Adaptive Conjoint Analysis (NCT02608307) | St. Jude Children's Research Hospital | 2016-02-09 |
| Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma (NCT02710565) | Mid and South Essex NHS Foundation Trust | 2016-02-01 |
| MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma (NCT02733887) | Guangxi Medical University | 2016-02-01 |
| Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain (NCT03407430) | UNC Lineberger Comprehensive Cancer Center | 2016-01-27 |
| Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies (NCT03076437) | Shenzhen Institute for Innovation and Translational Medicine | 2016-01-15 |
| The Value of Systematic Biopsies During Vertebroplasty for the Treatment of Osteoporotic Vertebral Fractures (NCT06153576) | Centre Hospitalier Universitaire de Nice | 2016-01-01 |
| Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer (NCT02821793) | Institut Bergonié | 2016-01-01 |
| A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma (NCT02532192) | M.D. Anderson Cancer Center | 2015-12-01 |
| PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation (NCT02905942) | Peking University | 2015-12-01 |
| Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma (NCT01528865) | University of Michigan Rogel Cancer Center | 2015-12-01 |
| Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO) (NCT02605694) | SecuraBio | 2015-12-01 |
| Illness Management and Parental Adjustment to Cancer Treatment (NCT02505165) | Children's Hospital Medical Center, Cincinnati | 2015-11-19 |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (NCT02419469) | M.D. Anderson Cancer Center | 2015-11-13 |
| Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis (NCT02593123) | Virginia Commonwealth University | 2015-11-04 |
| A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma (NCT02529852) | M.D. Anderson Cancer Center | 2015-11-04 |
| Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies (NCT02694913) | Weill Medical College of Cornell University | 2015-11-01 |
| Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma (NCT02598570) | AbbVie | 2015-11-01 |
| Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation (NCT02598752) | Memorial Sloan Kettering Cancer Center | 2015-11-01 |
| A Study of the Safety and Efficacy of EBV Specific T-cell Lines (NCT02580539) | Dr. Jean-Sebastien Delisle, MD, PhD | 2015-11-01 |
| Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma (NCT02436707) | Canadian Cancer Trials Group | 2015-10-27 |
| A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase (NCT02369653) | Bristol-Myers Squibb | 2015-10-22 |
| URMC Related Haplo-identical Donor BMT (NCT02660281) | University of Rochester | 2015-10-01 |
| Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers (NCT02682953) | University of Maryland, Baltimore | 2015-10-01 |
| Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy (NCT02588560) | Chang Gung Memorial Hospital | 2015-09-01 |
| A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers (NCT02409121) | University of Michigan Rogel Cancer Center | 2015-09-01 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors (NCT02192333) | Fred Hutchinson Cancer Center | 2015-08-03 |
| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention (NCT02423915) | M.D. Anderson Cancer Center | 2015-07-30 |
| A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab (NCT02518958) | EpicentRx, Inc. | 2015-07-21 |
| Non-interventional Study on TEAM Conditioning in Patients With Lymphoma (TEAM) (NCT02504190) | Association for Training, Education, and Research in Hematology, Immunology, and Transplantation | 2015-07-16 |
| Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas (NCT02503423) | Taiho Oncology, Inc. | 2015-07-14 |
| Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma (NCT02728882) | Sinobioway Cell Therapy Co., Ltd. | 2015-07-02 |
| Umbilical Cord Blood Transplantation From Unrelated Donors (NCT03016806) | University of Rochester | 2015-06-01 |
| Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors (NCT02929615) | Peking University | 2015-06-01 |
| Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT) (NCT02169505) | M.D. Anderson Cancer Center | 2015-05-22 |
| Carfilzomib With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT02187133) | University of California, San Francisco | 2015-05-05 |
| Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT02414724) | Roswell Park Cancer Institute | 2015-05-01 |
| African American Cancer Clinical Trial Decisions: Testing Tailored Messages (NCT02356549) | Virginia Commonwealth University | 2015-05-01 |
| Tenofovir to Prevent HBV Reactivation (NCT02186574) | University Health Network, Toronto | 2015-05-01 |
| Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin (NCT02423356) | Daniel Rushing | 2015-04-23 |
| Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma (NCT02269085) | M.D. Anderson Cancer Center | 2015-04-20 |
| Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer (NCT02260414) | Centre Hospitalier Universitaire de Saint Etienne | 2015-04-14 |
| Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) (NCT02347878) | Sun Yat-sen University | 2015-04-01 |
| Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme) (NCT02408042) | Western Regional Medical Center | 2015-04-01 |
| Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies (NCT02456350) | Shenzhen Second People's Hospital | 2015-04-01 |